Emerging multidrug-resistant hybrid pathotype shiga toxin-producing escherichia coil O80 and related strains of clonal complex 165, Europe
Loading...
Identifiers
ISSN: 1080-6040
E-ISSN: 1080-6059
Publication date
Advisors
Tutors
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Centers for Disease Control and Prevention
Abstract
Enterohemorrhagic Escherichia coli serogroup O80, involved
in hemolytic uremic syndrome associated with extraintestinal
infections, has emerged in France. We obtained circularized
sequences of the O80 strain RDEx444, responsible for hemolytic uremic syndrome with bacteremia, and noncircularized
sequences of 35 O80 E. coli isolated from humans and animals in Europe with or without Shiga toxin genes. RDEx444
harbored a mosaic plasmid, pR444_A, combining extraintestinal virulence determinants and a multidrug resistance–
encoding island. All strains belonged to clonal complex 165,
which is distantly related to other major enterohemorrhagic E.
coli lineages. All stx-positive strains contained eae-ξ, ehxA,
and genes characteristic of pR444_A. Among stx-negative
strains, 1 produced extended-spectrum β-lactamase, 1 harbored the colistin-resistance gene mcr1, and 2 possessed
genes characteristic of enteropathogenic and pyelonephritis
E. coli. Because O80–clonal complex 165 strains can integrate intestinal and extraintestinal virulence factors in combination with diverse drug-resistance genes, they constitute
dangerous and versatile multidrug-resistant pathogens
Description
Bibliographic citation
Cointe, A., Birgy, A., Mariani Kurkdjian, P., Logouri, S., Courroux, C., Blanco, J. et al. (2018). Emerging multidrug-resistant hybrid pathotype shiga toxin–producing escherichia coli O80 and related strains of clonal complex 165, Europe. Emerg. Infect. Dis., vol. 24,12, 2062-2069
Relation
Has part
Has version
Is based on
Is part of
Is referenced by
Is version of
Requires
Publisher version
https://doi.org/10.3201/eid2412.180272Sponsors
We thank Roger Stephan and Lothar Beutin for providing the
strains from Switzerland and Germany, respectively.
This work was financed by Fonds d’Etudes et de Recherche du
Corps Médical, AP-HP. Work in the Laboratorio de Referencia
de Escherichia coli was financed by grant no. ED431C-2017-57
from Consellería de Cultura, Educación e Ordenación
Universitaria (Xunta de Galicia) and the European Regional
Development Fund
Rights
© 2018 by the authors. Licensee Centers for Disease Control and Prevention. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/)








